Charlson comorbidity index predicts the 10-year survivorship of the operatively treated hip fracture patients

Eur J Orthop Surg Traumatol. 2023 May;33(4):1141-1148. doi: 10.1007/s00590-022-03259-2. Epub 2022 Apr 18.

Abstract

Purpose: The aim of this study was to determine how Charlson comorbidity index (CCI) predicts the 10-year survival of operatively treated hip fracture patients aged ≥ 65 years.

Methods: This retrospective cohort study included all consecutive patients who had a hip fracture and were operatively treated upon in the study period from 01 January 2007 to 31 December 2007 at the university hospital. The clinical patient data were obtained from the medical records, and CCI score was calculated. The CCI predicts the 10-year mortality for a patient who may have a range of 22 comorbid conditions. Cumulative survival and complications were evaluated in terms of gender.

Results: A total of 241 hip fractures were studied; of these, 183/241 (76%) were females. A total of 32/241 (15%) complications were found, of which 26/241 (11%) were considered major. Overall, 213/241 (88%) patients died during the 10 years of follow-up. Cumulative survival estimates for females were 13% at 10 years (SE = 0.3, 95% CI 3.8-4.8), and for males, it was 12% at 10 years (SE = 0.5, 95% CI 2.8-4.6) (p = 0.33). CCI was significantly associated with mortality after the hip fracture as patients with CCI scores ≥ 4 were at a 3.1-8.5 times higher risk of death compared to patients with low CCI scores of 2-3 (p < 0.001).

Conclusion: Complications are common after operatively treated hip fracture. Advanced age, living in a care facility, ASA class 4 and high CCI score ≥ 4 were risk factors of mortality after the operatively treated hip fracture.

Keywords: Charlson comorbidity index; Complications; Femoral neck fractures; Hip fractures; Mortality; Outcome; Pertrochanteric fracture; Proximal femoral fractures; Survival.

MeSH terms

  • Comorbidity
  • Female
  • Hip Fractures* / surgery
  • Humans
  • Male
  • Retrospective Studies
  • Risk Factors
  • Survivorship*